Molecular Formula | C26H31N7O4S |
Molar Mass | 537.63 |
Density | 1.407±0.06 g/cm3(Predicted) |
Boling Point | 890.3±75.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
pKa | 10.35±0.10(Predicted) |
Storage Condition | 2-8°C |
In vitro study | Mps1-IN-3 is a potent MPS1 kinase inhibitor, with an IC 50 of 50 nM. Mps1-IN-3 inhibits the proliferation of U251 glioblastoma cells with an IC 50 of appr 5 µM. Mps1-IN-3 (2 μM) can completely abrogates checkpoint. |
In vivo study | Mps1-IN-3 (2 mg/kg, i.v.) sensitizes glioblastoma cells in murine tumor models, with prolonged survival and no toxicity. |
Hazard Symbols | Xn - Harmful![]() |
Risk Codes | 22 - Harmful if swallowed |
Safety Description | 46 - If swallowed, seek medical advice immediately and show this container or label. |
biological activity | Mps1-IN-3 is a potent, selective MPS1 inhibitor with an IC50 value of 50 nM. |
Target | Mps1 50 nM (IC 50 ) |
in vitro study | Mps1-IN-3 is a pot MPS1 kinase inhibitor, with an IC 50 of 50 nM. Mps1-IN-3 inhibit the propagation of U251 gliobastoma cells with an IC 50 of appr 5 µm. Mps1-IN-3 (2 μm) can complete abrogates checkpoint. |
in vivo study | Mps1-IN-3 (2 mg/kg, I. v.) sensitizes gliobastoma cells in murine tumor models, with prolongated survival and no toxicity. |